Cell Signaling Technology

Chk2 (E7L7J) Rabbit Monoclonal Antibody

#64691 · $175

3
Citing papers
100
Combined citations
Supplier page Find this product

Research areas

Muscle Physiology and Disorders2Muscle metabolism and nutrition1PI3K/AKT/mTOR signaling in cancer1Quinazolinone synthesis and applications1RNA modifications and cancer1RNA Research and Splicing1Coenzyme Q10 studies and effects1Synthesis and biological activity1

Papers citing this product

1
Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy
Nature Communications·2021·56 cit.·DOI
2
Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway
International Journal of Molecular Sciences·2022·25 cit.·DOI
3
EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis
Physiological Reports·2014·19 cit.·DOI

Similar products

ProductVendorPricePapers
Chk2 (1C12) Mouse Monoclonal AntibodyMouseCell Signaling Technology$148100
Chk2 (D9C6) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$161100
Chk2 AntibodyRabbitCell Signaling Technology$135100
Chk2 (1C12) Mouse Monoclonal Antibody (BSA and Azide Free)MouseCell Signaling Technology$86531
Chk2 (E7L7J) Rabbit Monoclonal Antibody — Evidence — PubIndex